Thymalfasin (Shenzhen Neptunus Interlong Bio-Technique)

重组人胸腺肽α1（深圳海王）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameThymalfasin (Shenzhen Neptunus Interlong Bio-Technique)
Drug Alias NameTimalfasina (Shenzhen Neptunus Interlong Bio-Technique)胸腺法新Recombinant human thymosin-α-1 (Shenzhen Neptunus Interlong Bio-Technique)Thymalfasinum (Shenzhen Neptunus Interlong Bio-Technique)Thymalfasine (Shenzhen Neptunus Interlong Bio-Technique)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionTh1 cells stimulantsTh2 cells inhibitors
TargetsNot applicable
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShenzhen Neptunus Interlong Bio-Technique Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Neptunus Interlong Bio-Technique Co Ltd
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A